Topoisomerases are enzymes that regulate the overwinding or underwinding of DNA.DNA's double-helical structure is entwined, which leads to the winding issue. Isomerization enzymes called topoisomerases work on DNA's topology. One strand of a DNA double helix is cut by type I topoisomerase, which is followed by relaxation and reannealing of the cut strand. Type I topoisomerases are divided into two subclasses: type IB topoisomerases, which employ a controlled rotary mechanism, and type IA topoisomerases, which share many structural and mechanistic features with the type II topoisomerases. One DNA double helix's two strands are cut by Type II topoisomerase, which then reanneals the cut strands after passing through another DNA double helix that hasn't been broken. Type IIA and type IIB topoisomerases, two subclasses of this class with related structures and mechanisms, are further divided.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
V78993 | (1R,9R)-Exatecan mesylate ((1R,9R)-DX8951f) | 2938875-39-7 | (1R,9R)-Exatecan mesylate((1R,9R)-DX8951f) is an isomer of Exatecan mesylate. | |
V55245 | (1S,9R)-Exatecan mesylate ((1S,9R)-DX8951f) | 2938875-54-6 | (1S,9R)-Exatecan mesylate ((1S,9R)-DX8951f) is an isomer of Exatecan mesylate . | |
V55246 | (4-NH2)-Exatecan | 2495742-21-5 | (4-NH2)-Exatecan is a topoisomerase inhibitor analogue that may be utilized in the synthesis/preparation of active molecules for antibody conjugation (ADC). | |
V88354 | (4-NH2)-Exatecan-d5 | (4-NH2)-Exatecan-d5 is a deuterated (4-NH2)-Exatecan. | ||
V88362 | (5-Cl)-Exatecan | 2813268-66-3 | (5-Cl)-Exatecan (compound 1-5) is a potent inhibitor of DNA topoisomerase and can be used in cancer research. | |
V88359 | (R)-(4-NH2)-Exatecan | (R)-(4-NH2)-Exatecan is the R-isomer of (4-NH2)-Exatecan (compound A). | ||
V101262 | 10-Boc-SN-38 | 362497-15-2 | 10-Boc-SN-38 is the tert-butyloxycarbonyl (Boc) protected form of SN-38. | |
V3121 | (±)-10-Hydroxycamptothecin | 64439-81-2 | 10-Hydroxycamptothecin, a naturally occuring indole alkaloid isolated from Camptotheca acuminate, is a cell-permeable and potent inhibitor of topoisomerase I. | |
V56564 | 12-Ethyl-9-hydroxycamptothecin | 119577-28-5 | 12-Ethyl-9-hydroxycamptothecin is an analogue of Camptothecin. | |
V88395 | 2-MSP-5-HA-GGFG-NH-CH2-O-CH2-CO-Exatecan | 2964536-59-0 | 2-MSP-5-HA-GGFG-NH-CH2-O-CH2-CO-Exatecan is a drug-linker conjugate for ADC, which consists of a cleavable linker and Exatecan. | |
V88791 | 3-Fluoro-evodiamine glucose | 3-Fluoro-evodiamine glucose (Compound 8) is a evodiamine-glucose conjugate. | ||
V55247 | 9-Chloromethyl-10-hydroxy-11-F-Camptothecin | 2414594-22-0 | 9-Chloromethyl-10-Hydroxy-11-F-Camptothecin? is a new camptothecin analogue. | |
V88373 | ADC Control Human IgG1-Deruxtecan | ADC Control Human IgG1-Deruxtecan is a human monoclonal antibody that is an isotype control for ADC human IgG1-Deruxtecan and can inhibit DNA topoisomerase I. | ||
V78289 | AHr | AuM1Phe is an N-heterocyclic carbene (NHC) metal complex that blocks human topoisomerase I activity and actin polymerization. | ||
V88254 | Alloc-DOX | 561022-65-9 | Alloc-DOX (N-Alloc doxorubicin) is a prodrug of doxorubicin. | |
V94204 | Amsacrine (gluconate) | 80277-07-2 | Amsacrine gluconate is a tumor cell DNA intercalator that also inhibits topoisomerase II. | |
V88802 | Antibacterial agent 229 | Antibacterial agent 229 (compound 8a) is a potent antibacterial agent. | ||
V98846 | Antibacterial agent 236 | 2364479-10-5 | Antimicrobial agent 236 (compound 4l) is an orally active DNA gyrase and topoisomerase IV inhibitor (IC50 of 3.2 and 300 nM, respectively, in Staphylococcus aureus) with broad-spectrum antimicrobial activity. | |
V88798 | Anticancer agent 214 | 2916404-95-8 | Anticancer agent 214 (2) is a camptothecin compound with IC50 values of 2.6 nM and 15.7 nM for MCF-7 and MDA-MB-231 cells, respectively. | |
V88793 | Anticancer agent 215 | 2916404-93-6 | Anticancer agent 215 (1) is a camptothecin compound with IC50 values of 5.2 nM and 8.2 nM for MCF-7 and MDA-MB-231 cells, respectively. |